Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Rituximab 500 / Bendamustine 70, Chronic Lymphocytic Leukemia, second-line, cycle 2-6

Protocol-ID: 683 V1.0 (Mini), R-BENDA (RITU500/BEND70), CLL, second line, C2-6

Indication(s)

  • Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma; ICD-10 C91.1-
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 20.05.2016